Fundraising Fox
ITM
Founded 2004 · 653 employees on LinkedIn · 2 known investors
Find your way into ITM
164 people in our graph share verified history with the ITM team — schools, employers, funds. One of them is your warm intro.
Raoul van Aalstunlockedknows Alexander Pironi · together at TenneT (overlapped)
×5knows the team · via Sparkasse-Finanzgruppe
×6knows the team · via University of Strathclyde
ITM is a vertically integrated biotechnology company specializing in precision oncology through radioisotope production and radiopharmaceutical development, with clinical programs advanced through subsidiary Lumara Bio. The company manufactures and supplies medical radioisotopes including Lutetium-177 and Actinium-225 for cancer detection and treatment.
Founders & leadership
AP
Alexander PironiExecutive Vice President, Global Head of RadioisotopesAlexander Pironi holds an EMBA from IESE Business School (2022) and brings over 10 years of commercial experience, including 6+ years in the pharmaceutical industry and 4+ years in managerial roles focused on cost budgeting, strategic planning, and organizational leadership. He has held various positions of increasing responsibility at ITM SE, a radioisotope and radiopharmaceutical company.
DK
Dr. Konstantin ZhernosekovChief Scientific Officer & Managing Director ITM Medical Isotopes & ITM Oncologics
Investors · 2
In the news
Frequently asked questions
- What does ITM do?
- ITM is a vertically integrated biotechnology company specializing in precision oncology through radioisotope production and radiopharmaceutical development, with clinical programs advanced through subsidiary Lumara Bio. The company manufactures and supplies medical radioisotopes including Lutetium-177 and Actinium-225 for cancer detection and treatment.
- Who are ITM's investors?
- ITM's investors include Capmont, Nextech Invest.